IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Drug Transporters as Targets for Cancer Chemotherapy. T. NAKANISHI (Baltimore, MD, USA). Cancer Genomics & Proteomics 4: 241-254, 2007.
Molecular Targets in Metastasis: Lessons from Genomic Approaches.
B. FINGLETON (Nashville, TN, USA). Cancer Genomics & Proteomics 4: 211-222, 2007.
Tailoring-targeted Therapy to Individual Patients: Lessons to be Learnt from the Development of Mitomycin C.
M. VOLPATO, R.M. PHILLIPS (Bradford, UK). Cancer Genomics & Proteomics 4: 175-186, 2007.
Cancer Stem Cells and Individualized Therapy.
S. CHUMSRI, P. PHATAK, M.J. EDELMAN, N. KHAKPOUR, A.W. HAMBURGER, A.M. BURGER (Baltimore, MD, USA). Cancer Genomics & Proteomics 4: 165-174, 2007.
Development of Reverse Phase Protein Microarrays for Clinical Applications and Patient-tailored Therapy.
R. SPEER, J. WULFKUHLE, V. ESPINA, R. AURAJO, K.H. EDMISTON, L.A. LIOTTA, E.F. PETRICOIN III (Tübingen, Germany; Manassas; Falls Church, VA, USA). Cancer Genomics & Proteomics 4: 157-164, 2007.
Individualization of Therapy Using Mammaprint®TM: from Development to the MINDACT Trial.
S. MOOK, L.J. VAN’T VEER, E.J.T. RUTGERS, M.J. PICCART-GEBHART, F. CARDOSO (Amsterdam, The Netherlands; Brussels, Belgium). Cancer Genomics & Proteomics 4: 147-156, 2007.
Application of Array-based Genomic and Epigenomic Technologies to Unraveling the Heterogeneous Nature of Breast Tumors: On the Road to Individualized Treatment.
M. ABRAMOVITZ, B. LEYLAND-JONES (Montreal, QC, Canada; Atlanta, GA, USA). Cancer Genomics & Proteomics 4: 135-146, 2007.
Contribution of DNA and Tissue Microarray Technology to the Identification and Validation of Biomarkers and Personalised Medicine in Breast Cancer.
D.J. BRENNAN, C. KELLY, E. REXHEPAJ, P.A. DERVAN, M.J. DUFFY, W.M. GALLAGHER (Dublin, Ireland). Cancer Genomics & Proteomics 4: 121-134, 2007.
Basics of Diagnostic DNA Microarray Technology. Case Study: Hepatocellular Carcinoma.
A. EL-ANEED, J. BANOUB (St. John’s, NL, Canada). Cancer Genomics & Proteomics 3: 311-316, 2006.
Proteomics in Cancer Research and Diagnosis; An Update.
V. IFANDI, S.E. SLADE, M. KHAN (Coventry, UK). Cancer Genomics & Proteomics 3: 253-264, 2006.
Considerations Regarding the Use of Blood Samples in the Proteomic Identification of Biomarkers for Cancer Diagnosis.
C.V. SAPAN, R.L. LUNDBLAD (Chapel Hill, NC, USA). Cancer Genomics & Proteomics 3: 227-230, 2006.
Laser Microdissection: Application to Carcinogenesis.
F.E. AHMED (Greenville, NC, USA). Cancer Genomics & Proteomics 3: 217-226, 2006.
Metastasis Promoter S100A4 is a Potential Molecular Therapeutic Target.
G.V. SHERBET (Newcastle upon Tyne, UK; Huntington Beach, CA, USA). Cancer Genomics & Proteomics 3: 203-216, 2006.
Gene Expression Microarray Technology: Some Applications in Lung Cancer Research.
L. BREEN, L. O’DRISCOLL, M. CLYNES (Dublin, Ireland). Cancer Genomics & Proteomics 3: 197-202, 2006.
Molecular Replacement for Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy.
G.L. NICOLSON, K.A. CONKLIN (Huntington Beach; Los Angeles, CA, USA). Cancer Genomics & Proteomics 3: 159-168, 2006.
Design of Nanoparticles as Drug Carriers for Cancer Therapy.
J. ZHANG, C.Q. LAN, M. POST, B. SIMARD, Y. DESLANDES, T.H. HSIEH (Ottawa, ON, Canada). Cancer Genomics & Proteomics 3: 147-158, 2006.
Genomic Instability and Breast Cancer Progression.
S. INGVARSSON (Reykjavik, Iceland). Cancer Genomics & Proteomics 3: 137-146, 2006.
RNA Interference with siRNA.
H. JOYCE, I. BRAY, M. CLYNES (Dublin, Ireland). Cancer Genomics & Proteomics 3: 127-136, 2006.
Proteomics and Bioinformatics in Biomedical Research.
T. KISLINGER, I. JURISICA (Toronto, ON, Canada). Cancer Genomics & Proteomics 3: 11-28, 2006.
Gene Expression and Proteomic Analysis of Pancreatic Cancer: a Recent Update.
R. CHEN, S. PAN, D.A. CRISPIN, T.A. BRENTNALL (Seattle, WA, USA). Cancer Genomics & Proteomics 3: 1-10, 2006.
Quantitative Real-time RT-PCR: Application to Carcinogenesis.
F.E. AHMED (Greenville, NC, USA). Cancer Genomics & Proteomics 2: 317-332, 2005.
Phylogenetics: Applications, Software and Challenges.
A. STAMATAKIS (Heraklion, Greece). Cancer Genomics & Proteomics 2: 301-305, 2005.
Application of Microarrays for the Prediction of Therapy Response in Breast Cancer.
B. GYÖRFFY, P. SUROWIAK, H. LAGE (Berlin, Germany; Budapest, Hungary; Wroclaw, Poland). Cancer Genomics & Proteomics 2: 255-264, 2005.
Tumor Suppressor Genes on Human Chromosome 3 and Cancer Pathogenesis.
S. INGVARSSON (Reykjavik, Iceland). Cancer Genomics & Proteomics 2: 247-254, 2005.
Stathmin in Cell Proliferation and Cancer Progression.
G.V. SHERBET, F. CAJONE (Newcastle-upon-Tyne, U.K.; Huntington Beach, CA, U.S.A.; Milan, Italy). Cancer Genomics & Proteomics 2: 227-238, 2005.
Using Comparative Genomics to Leverage Animal Models in the Identification of Cancer Genes. Examples in Prostate Cancer.
M.W. DATTA, M.A. SUCKOW, S. TWIGGER, M. POLLARD, H. JACOB, P.J. TONELLATO (Atlanta, GA; Notre Dame, IN; Milwaukee, WI, USA). Cancer Genomics & Proteomics 2: 137-144, 2005.
Page: 1 2 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system